Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Singal, J. Vanwert (2001)
De novo methylation of an embryonic globin gene during normal development is strand specific and spreads from the proximal transcribed region.Blood, 98 12
Jianxiang Wang, T. Hoshino, R. Redner, S. Kajigaya, Johnson Liu (1998)
ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.Proceedings of the National Academy of Sciences of the United States of America, 95 18
Seung Dong, G. Traverso, Constance Johnson, L. Geng, R. Favis, K. Boynton, K. Hibi, S. Goodman, M. D'Allessio, P. Paty, S. Hamilton, D. Sidransky, F. Barany, B. Levin, A. Shuber, K. Kinzler, B. Vogelstein, Jin Jen (2001)
Detecting colorectal cancer in stool with the use of multiple genetic targets.Journal of the National Cancer Institute, 93 11
Yan Fang, X. Guan, Yin Guo, J. Sham, Man-quan Deng, Q. Liang, Huimei Li, Hongen Zhang, Hang Zhou, J. Trent (2001)
Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridizationGenes, 30
A. Agathanggelou, S. Honorio, D. Macartney, Alonso Martínez, A. Dallol, J. Rader, P. Fullwood, A. Chauhan, R. Walker, J. Shaw, S. Hosoe, M. Lerman, J. Minna, E. Maher, F. Latif (2001)
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumoursOncogene, 20
Yue Cheng, Nicholas Poulos, M. Lung, Garret Hampton, Baoxiang Ou, Michael Lerman, Eric Stanbridge (1998)
Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3.Proceedings of the National Academy of Sciences of the United States of America, 95 6
P. Effert, R. Mccoy, Mohamed Abdel-Hamid, K. Flynn, Qing Zhang, Pierre Busson, Thomas Tursz, Edison Liu, N. Raab-Traub (1992)
Alterations of the p53 gene in nasopharyngeal carcinomaJournal of Virology, 66
E. Zabarovsky, M. Lerman, J. Minna (2002)
Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancersOncogene, 21
S. Tsao, Xianghong Wang, Yu Liu, Y. Cheung, H. Feng, Z-M Zheng, N. Wong, P. Yuen, A. Lo, Y. Wong, D. Huang (2002)
Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes.Biochimica et biophysica acta, 1590 1-3
A. Balmain (2002)
Cancer: New-age tumour suppressorsNature, 417
P. Feng, E. Ren, D. Liu, S. Chan, Huaizhong Hu (2000)
Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis.The Journal of general virology, 81 Pt 10
D. Burbee, É. Forgács, S. Zöchbauer-Müller, L. Shivakumar, K. Fong, B. Gao, Dwight Randle, M. Kondo, A. Virmani, S. Bader, Y. Sekido, F. Latif, S. Milchgrub, S. Toyooka, A. Gazdar, M. Lerman, E. Zabarovsky, Michael White, J. Minna (2001)
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.Journal of the National Cancer Institute, 93 9
J. Graff, E. Gabrielson, Hiraoki Fujii, S. Baylin, J. Herman (2000)
Methylation Patterns of the E-cadherin 5′ CpG Island Are Unstable and Reflect the Dynamic, Heterogeneous Loss of E-cadherin Expression during Metastatic Progression*The Journal of Biological Chemistry, 275
Y. Tsang, K. Lo, S. Leung, P. Choi, Yin Fong, Joesph Lee, D. Huang (1999)
Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinomaInternational Journal of Cancer, 83
Si-zhong Zhang, Gao Xiukung, Z. Yi (1983)
Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinomaInternational Journal of Cancer, 31
K. Kok, S. Naylor, C. Buys (1997)
Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes.Advances in cancer research, 71
H. Kourea, I. Orlow, B. Scheithauer, C. Cordon-Cardo, J. Woodruff (1999)
Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.The American journal of pathology, 155 6
(2001)
Cancer Genet
S. Smale (1997)
Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes.Biochimica et biophysica acta, 1351 1-2
P. Murray, Guo-Hua Qiu, L. Fu, Elyse Waites, G. Srivastava, Duncan Heys, A. Agathanggelou, F. Latif, R. Grundy, J. Mann, J. Starczynski, J. Crocker, S. Parkes, R. Ambinder, L. Young, Q. Tao (2004)
Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphomaOncogene, 23
(1992)
Semin
Majida Jalbout, N. Bouaouina, J. Gargouri, M. Corbex, S. Ahmed, L. Chouchane (2003)
Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma.Cancer letters, 193 1
P. Busson, G. Ganem, P. Flores, F. Mugneret, B. Clausse, B. Caillou, K. Braham, H. Wakasugi, M. Lipinski, T. Tursz (1988)
Establishment and characterization of three transplantable EBV‐containing nasopharyngeal carcinomasInternational Journal of Cancer, 42
L. Deng, Ning Jing, G. Tan, Ming Zhou, F. Zhan, Y. Xie, L. Cao, Guiyuan Li (1998)
A common region of allelic loss on chromosome region 3p25.3–26.3 in nasopharyngeal carcinomaGenes, 23
E. Evron, W. Dooley, C. Umbricht, D. Rosenthal, N. Sacchi, E. Gabrielson, A. Soito, David Hung, B. Ljung, N. Davidson, S. Sukumar (2001)
Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCRThe Lancet, 357
Yann-Jang Chen, J. Ko, Pei-Jer Chen, C. Shu, M. Hsu, S. Tsai, Chi-Hung Lin (1999)
Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridizationGenes, 25
Carvell Nguyen, G. Liang, Tuny Nguyen, D. Tsao-Wei, S. Groshen, M. Lübbert, J. Zhou, W. Benedict, P. Jones (2001)
Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.Journal of the National Cancer Institute, 93 19
L. Hu, G. Eiriksdottir, T. Lebedeva, Irina Kholodniouk, A. Alimov, Fu Chen, Yan Luo, E. Zabarovsky, S. Ingvarsson, G. Klein, I. Ernberg (1996)
Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinomaGenes, 17
Q. Tao, L. Swinnen, J. Yang, G. Srivastava, K. Robertson, R. Ambinder (1999)
Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis.The American journal of pathology, 155 2
D. Astuti, A. Agathanggelou, S. Honorio, A. Dallol, T. Martinsson, P. Kogner, Carol Cummins, H. Neumann, R. Voutilainen, P. Dahia, C. Eng, E. Maher, F. Latif (2001)
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumoursOncogene, 20
Q. Tao, K. Robertson, A. Manns, A. Hildesheim, R. Ambinder (1998)
Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue.Blood, 91 4
Oncogene , 20 , 7573 – 7577 . Balmain A . ( 2002 )
S. Baylin, J. Herman, J. Graff, P. Vertino, J. Issa (1998)
Alterations in DNA methylation: a fundamental aspect of neoplasia.Advances in cancer research, 72
D. Huang, K. Lo, P. Choi, A. Ng, S. Tsao, G. Yiu, Joseph Lee (1991)
Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma.Cancer genetics and cytogenetics, 54 1
L. Giot, J. Bader, Cory Brouwer, Amitabha Chaudhuri, B. Kuang, Ying Li, Y. Hao, C. Ooi, B. Godwin, E. Vitols, G. Vijayadamodar, P. Pochart, H. Machineni, M. Welsh, Yong Kong, B. Zerhusen, Rachel Malcolm, Z. Varrone, A. Collis, M. Minto, S. Burgess, L. McDaniel, E. Stimpson, F. Spriggs, J. Williams, K. Neurath, N. Ioime, M. Agee, E. Voss, K. Furtak, R. Renzulli, N. Aanensen, S. Carrolla, E. Bickelhaupt, Y. Lazovatsky, A. Dasilva, J. Zhong, C. Stanyon, R. Finley, K. White, Michael Braverman, T. Jarvie, S. Gold, M. Leach, James Knight, R. Shimkets, M. McKenna, J. Chant, J. Rothberg (2003)
A Protein Interaction Map of Drosophila melanogasterScience, 302
Q. Tao, He Huang, T. Geiman, C. Lim, L. Fu, Guo-Hua Qiu, K. Robertson (2002)
Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells.Human molecular genetics, 11 18
K. Dreijerink, E. Braga, I. Kuzmin, L. Geil, F. Duh, D. Angeloni, B. Zbar, M. Lerman, E. Stanbridge, J. Minna, A. Protopopov, Jingfeng Li, V. Kashuba, G. Klein, E. Zabarovsky (2001)
The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesisProceedings of the National Academy of Sciences of the United States of America, 98
R. Dammann, Chun Li, J. Yoon, P. Chin, S. Bates, G. Pfeifer (2000)
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3Nature Genetics, 25
D. Macleod, J. Charlton, J. Mullins, A. Bird (1994)
Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island.Genes & development, 8 19
S. Cheung, D. Huang, A. Hui, K. Lo, C. Ko, Y. Tsang, N. Wong, B. Whitney, Joseph Lee (1999)
Nasopharyngeal carcinoma cell line (C666‐1) consistently harbouring Epstein‐Barr virusInternational Journal of Cancer, 83
R. Leboeuf, Elisabeth Ban, Marino Green, A. Stone, S. Propst, J. Blalock, J. Tauber (1998)
Molecular Cloning, Sequence Analysis, Expression, and Tissue Distribution of Suppressin, a Novel Suppressor of Cell Cycle Entry*The Journal of Biological Chemistry, 273
M. Turker (2002)
Gene silencing in mammalian cells and the spread of DNA methylationOncogene, 21
N. Sung, Y. Zeng, N. Raab-Traub (2000)
Alterations on chromosome 3 in endemic and nonendemic nasopharyngeal carcinomaInternational Journal of Cancer, 86
G. Srivastava, K. Wong, A. Chiang, K. Lam, Q. Tao (2000)
Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state.Blood, 95 7
R. Glaser, Hai‐ying Zhang, K. Yao, He-cheng Zhu, Fu‐Xi Wang, Guiyuan Li, Dong‐Seng Wen, Ying‐Ping Li (1989)
Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.Proceedings of the National Academy of Sciences of the United States of America, 86 23
P. Wijermans, M. Lübbert, G. Verhoef, A. Bosly, C. Ravoet, M. André, A. Ferrant (2000)
Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 5
R. Armstrong, P. Imrey, Munn Lye, M. Armstrong, M. Yu, S. Sani (2000)
Nasopharyngeal carcinoma in Malaysian Chinese: occupational exposures to particles, formaldehyde and heat.International journal of epidemiology, 29 6
A. Hui, K. Lo, S. Leung, P. Teo, Michael Fung, K. To, N. Wong, P. Choi, Joseph Lee, D. Huang (1999)
Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisationInternational Journal of Cancer, 82
M. Campanero, M. Armstrong, E. Flemington (2000)
CpG methylation as a mechanism for the regulation of E2F activity.Proceedings of the National Academy of Sciences of the United States of America, 97 12
(1997)
Biochim
Gary Chien, P. Yuen, D. Kwong, Yok-Lam Kwong (2001)
Comparative genomic hybridization analysis of nasopharygeal carcinoma: consistent patterns of genetic aberrations and clinicopathological correlations.Cancer genetics and cytogenetics, 126 1
K. Robertson, S. Ait-Si-Ali, T. Yokochi, P. Wade, Peter Jones, A. Wolffe (2000)
DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promotersNature Genetics, 25
M. Gardiner-Garden, M. Frommer1v, ‘The Kanematsu (1987)
CpG islands in vertebrate genomes.Journal of molecular biology, 196 2
Loss of heterozygosity at 3p21 is common in various cancers including nasopharyngeal carcinoma (NPC). BLU is one of the candidate tumor suppressor genes (TSGs) in this region. Ectopic expression of BLU results in the inhibition of colony formation of cancer cells, suggesting that BLU is a tumor suppressor. We have identified a functional BLU promoter and found that it can be activated by environmental stresses such as heat shock, and is regulated by E2F. The promoter and first exon are located within a CpG island. BLU is highly expressed in testis and normal upper respiratory tract tissues including nasopharynx. However, in all seven NPC cell lines examined, BLU expression was downregulated and inversely correlated with promoter hypermethylation. Biallelic epigenetic inactivation of BLU was also observed in three cell lines. Hypermethylation was further detected in 19/29 (66%) of primary NPC tumors, but not in normal nasopharyngeal tissues. Treatment of NPC cell lines with 5-aza-2′-deoxycytidine activated BLU expression along with promoter demethylation. Although hypermethylation of RASSF1A, another TSG located immediately downstream of BLU, was detected in 20/27 (74%) of NPC tumors, no correlation between the hypermethylation of these two TSGs was observed (P=0.6334). In addition to methylation, homozygous deletion of BLU was found in 7/29 (24%) of tumors. Therefore, BLU is a stress-responsive gene, being disrupted in 83% (24/29) of NPC tumors by either epigenetic or genetic mechanisms. Our data are consistent with the interpretation that BLU is a TSG for NPC.
Oncogene – Springer Journals
Published: May 3, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.